assertion

Full identifier: http://purl.org/np/RAkoWjOLT2qrE5FkFd507XuQR_K1fZNURzy8ZrfscW01w#assertion

Minted in Nanopublication

 RAkoWjOLT2 comment approve/disapprove edit as derived nanopublication

This is a local identifier minted within the nanopublication. http://purl.org/np/RAkoWjOLT2...#sig sig http://purl.org/nanopub/x/hasSignatureTarget has as target This is the identifier for this whole nanopublication. http://purl.org/np/RAkoWjOLT2... this nanopublication .
This is a local identifier minted within the nanopublication. http://purl.org/np/RAkoWjOLT2...#sig sig http://purl.org/nanopub/x/hasAlgorithm has the algorithm (this is a literal) "RSA" .

References

Nanopublication Part Subject Predicate Object Published By Published On
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
assertion
Elif Ozkan
2022-10-06T11:45:23.837Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
assertion
2022-10-06T11:45:23.837701
Elif Ozkan
2022-10-06T11:45:23.837Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
assertion
Fosamprenavir calcium tablets are indicated in combination with other antiretroviral agents for the treatment of human immunodeficiency virus (HIV-1) infection. The protease inhibitor-experienced patient trial was not large enough to reach a definitive conclusion. Once-daily administration of fosampranavir. tabletsplus ritonavir is not recommended for adult. protease. inhibitor-expertienced patients or any pediatric patients. younger than 6 months.
Elif Ozkan
2022-10-06T11:45:23.837Z

Raw

TriG(txt), JSON-LD(txt), N-Quads(txt), XML(txt)